The status of cannabis in the UN drug conventions is controversial. It is now scheduled among the most dangerous substances. How and why did cannabis get in the conventions? Does it belong there? What are the options to review the status of cannabis according to current scientific data? Is making cannabis subject to a control regime similar to harmful substances like alcohol and tobacco a solution?
What are drugs and why are they controlled? What are the benefits and harms of taking drugs? How public health policies can address drug use? Learn the answers to these questions and more in the free online course 'Drugs, drug use, drug policy and health'.
How can we resolve the tensions between current drug control policies and states’ human rights obligations? The international human rights framework clearly establishes that, in the event of conflicts between obligations under the UN Charter and other international agreements, human rights obligations take precedence. As legally regulated cannabis markets start to grow, now is the time to secure a legitimate place for small farmers using alternative development, human rights and fair trade principles.
The International Narcotics Control Board (INCB) just released its annual report. Martin Jelsma - who has followed the Board's policy for many years now with a critical eye - examines its negative stance towards harm reduction and decriminalization, and questions the Board's tendency to overstep its mandate.
Allow countries and regions more space for policy reform using and stretching the margins of the conventions. Strengthen alliances of like-minded nations to support one another and effectively coordinate efforts at the UN level through informal consultations and strategy meetings. Any crack in the global prohibition regime would not plunge the world into chaos immediately. We should not press for a new global straitjacket but for a model that respects cultural differences. We have to open up the debate about the wisdom of the conventions as they stand.
The world-wide debate over cannabis reform appears to be gaining uncommon speed and unexpectedly it is in Latin America that the winds of change have greatest force. So where is Mexico in this panorama?
The world-wide debate over cannabis reform appears to be gaining uncommon speed and unexpectedly it is in Latin America that the winds of change have greatest force. So where is Mexico in this panorama? There are currently eight Bills on the question of marihuana gathering dust in the annals of various parliamentary commissions.
As the hemisphere’s leaders gather in Colombia this week for the VI Summit of the Americas, their on-camera discussions will be dominated by perennial convention topics: poverty, cooperation, the need for roads. But behind closed doors, they are expected to tackle a more contentious issue: the narcotics trade.
In 1976 the Netherlands adopted a formal written policy of non-enforcement for violations involving possession or sale of up to 30 g of cannabis. The ‘gateway theory’ has long been seen as an argument for being tough on cannabis, but interestingly, the Dutch saw that concept as a rationale for allowing retail outlets to sell small quantities. Rather than seeing an inexorable psychopharmacological link between marijuana and hard drugs, the Dutch hypothesized that the gateway mechanism reflected social and economic networks, so that separating the markets would keep cannabis users out of contact with hard-drug users and sellers.
The seminar entitled “Modernising the global drug control system – Can Europe lead?” was organised in the European Parliament by the International Drug Policy Consortium (IDPC), and the Global Commission on Drug Policy, and co-hosted by the Member of European Parliament (MEP) Nikos Chrysogelos. The event aimed to present the recommendations of the Global Commission and discuss the role that the European Union (EU) could play in current drug policy reform debates taking place within Europe and around the world. The seminar also comes at a time when the EU is working on drafting a new Drug Strategy to replace the one that will expire at the end of 2012.
This short film by the Hungarian Civil Liberties Union (HCLU), a grantee of the Open Society Global Drug Policy Program, outlines how the country successfully resolved these problems through the introduction of an innovative national drug policy based on scientifically proven methods, not rhetoric.
In a historic vote, the United Nations (UN) has finally recognised the medicinal value of cannabis.
A group of prominent drug policy organisations has welcomed the move, but also expressed disappointment that this reform does not go far enough, as cannabis remains categorised internationally alongside drugs like heroin and cocaine.
The review was revisiting cannabis scheduling decisions made in the 1950s, which were driven by prevailing racist and colonial attitudes, and not based on scientific evaluations. This has remained unchallenged.